Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis - PubMed (original) (raw)
Expression of human apolipoprotein A-I/C-III/A-IV gene cluster in mice induces hyperlipidemia but reduces atherogenesis
L Vergnes et al. Arterioscler Thromb Vasc Biol. 2000 Oct.
Abstract
The apolipoprotein (apo)A-I/C-III/A-IV gene cluster is involved in lipid metabolism and atherosclerosis. Overexpression of apoC-III in mice causes hypertriglyceridemia and induces atherogenesis, whereas overexpression of apoA-I or apoA-IV increases cholesterol in plasma high density lipoprotein (HDL) and protects against atherosclerosis. Each gene has been studied alone in transgenic mice but not in combination as the entire cluster. To determine which phenotype is produced by the expression of the entire gene cluster, transgenic mice were generated with a 33-kb human DNA fragment. The results showed that the transgene contained the necessary elements to direct hepatic and intestinal expression of the 3 genes. In the pooled data, plasma concentrations were 257+/-9, 7.1+/-0.5, and 1.0+/-0.2 mg/dL for human apoA-I, apoC-III, and apoA-IV, respectively (mean+/-SEM). Concentrations of these apolipoproteins were higher in males than in females. Human apoA-I and apoC-III concentrations were positively correlated, suggesting that they are coregulated. Transgenic mice exhibited gross hypertriglyceridemia and accumulation of apoB(48)-containing triglyceride-rich lipoproteins. Plasma triglyceride and cholesterol concentrations were correlated positively with human apoC-III concentration, and HDL cholesterol was correlated with apoA-I concentration. In an apoE-deficient background, despite being markedly hypertriglyceridemic, cluster transgenic animals compared with nontransgenic animals showed a 61% reduction in atherosclerosis. This suggests that apoA-I and/or apoA-IV can protect against atherosclerosis even in the presence of severe hyperlipidemia. These mice provide a new model for studies of the regulation of the 3 human genes in combination.
Similar articles
- Human apoA-I/C-III/A-IV gene cluster transgenic rabbits: effects of a high-cholesterol diet.
Recalde D, Baroukh N, Viglietta C, Prince S, Verona J, Vergnes L, Pidoux J, Nazeem Nanjee M, Brites F, Ochoa A, Castro G, Zakin MM, Miller NE, Marie Houdebine L. Recalde D, et al. FEBS Lett. 2004 Aug 13;572(1-3):294-8. doi: 10.1016/j.febslet.2004.07.041. FEBS Lett. 2004. PMID: 15304365 - Associations of allelic differences at the A-I/C-III/A-IV gene cluster with carotid artery intima-media thickness and plasma lipid transport in hypercholesterolemic-hypertriglyceridemic humans.
Patsch W, Sharrett AR, Chen IY, Lin-Lee YC, Brown SA, Gotto AM Jr, Boerwinkle E. Patsch W, et al. Arterioscler Thromb. 1994 Jun;14(6):874-83. doi: 10.1161/01.atv.14.6.874. Arterioscler Thromb. 1994. PMID: 8199177 - The apolipoprotein A-I/C-III/A-IV gene cluster: ApoC-III and ApoA-IV expression is regulated by two common enhancers.
Vergnes L, Taniguchi T, Omori K, Zakin MM, Ochoa A. Vergnes L, et al. Biochim Biophys Acta. 1997 Oct 18;1348(3):299-310. doi: 10.1016/s0005-2760(97)00071-4. Biochim Biophys Acta. 1997. PMID: 9366246 - The molecular biology of human apoA-I, apoA-II, apoC-II and apoB.
Law SW, Lackner KJ, Fojo SS, Hospattankar A, Monge JC, Brewer HB Jr. Law SW, et al. Adv Exp Med Biol. 1986;201:151-62. doi: 10.1007/978-1-4684-1262-8_14. Adv Exp Med Biol. 1986. PMID: 2432761 Review. - Role of apoA-II in lipid metabolism and atherosclerosis: advances in the study of an enigmatic protein.
Blanco-Vaca F, Escolà-Gil JC, Martín-Campos JM, Julve J. Blanco-Vaca F, et al. J Lipid Res. 2001 Nov;42(11):1727-39. J Lipid Res. 2001. PMID: 11714842 Review.
Cited by
- Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.
Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, Zhao XQ, Elkon K, Marcovina S, Ridker P, Oram JF, Heinecke JW. Vaisar T, et al. J Clin Invest. 2007 Mar;117(3):746-56. doi: 10.1172/JCI26206. J Clin Invest. 2007. PMID: 17332893 Free PMC article. - Overexpression of human apolipoprotein A-I preserves cognitive function and attenuates neuroinflammation and cerebral amyloid angiopathy in a mouse model of Alzheimer disease.
Lewis TL, Cao D, Lu H, Mans RA, Su YR, Jungbauer L, Linton MF, Fazio S, LaDu MJ, Li L. Lewis TL, et al. J Biol Chem. 2010 Nov 19;285(47):36958-68. doi: 10.1074/jbc.M110.127829. Epub 2010 Sep 16. J Biol Chem. 2010. PMID: 20847045 Free PMC article. - Apolipoprotein A-I: A Molecule of Diverse Function.
Mangaraj M, Nanda R, Panda S. Mangaraj M, et al. Indian J Clin Biochem. 2016 Jul;31(3):253-9. doi: 10.1007/s12291-015-0513-1. Epub 2015 Jul 16. Indian J Clin Biochem. 2016. PMID: 27382195 Free PMC article. Review. - Graded effects of proteinuria on HDL structure in nephrotic rats.
Shearer GC, Newman JW, Hammock BD, Kaysen GA. Shearer GC, et al. J Am Soc Nephrol. 2005 May;16(5):1309-19. doi: 10.1681/ASN.2004080644. Epub 2005 Mar 23. J Am Soc Nephrol. 2005. PMID: 15788471 Free PMC article. - Hypertriglyceridemia and delayed clearance of fat load in transgenic rabbits expressing human apolipoprotein CIII.
Ding Y, Wang Y, Zhu H, Fan J, Yu L, Liu G, Liu E. Ding Y, et al. Transgenic Res. 2011 Aug;20(4):867-75. doi: 10.1007/s11248-010-9467-5. Epub 2010 Dec 1. Transgenic Res. 2011. PMID: 21120692
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous